A clinical benchmark of public self-supervised pathology foundation models
Gabriele Campanella(Icahn School of Medicine at Mount Sinai), Chad Vanderbilt(Memorial Sloan Kettering Cancer Center), Ricky Kwan(Icahn School of Medicine at Mount Sinai), Ruchika Verma(Icahn School of Medicine at Mount Sinai), Kuan‐lin Huang(Icahn School of Medicine at Mount Sinai), Abdülkadir Elmas(Icahn School of Medicine at Mount Sinai), Jennifer Zeng(Icahn School of Medicine at Mount Sinai), Manbir Singh(National Dairy Research Institute), Noora Neittaanmäki(Sahlgrenska University Hospital), Jane Houldsworth(Icahn School of Medicine at Mount Sinai), Shengjia Chen(Icahn School of Medicine at Mount Sinai), Matt Croken(Icahn School of Medicine at Mount Sinai), Ivan Shujski(Sahlgrenska University Hospital), Silke Muehlstedt(Icahn School of Medicine at Mount Sinai), Adam J. Schoenfeld(Memorial Sloan Kettering Cancer Center), Brandon M. Veremis(Icahn School of Medicine at Mount Sinai), Aryeh Stock(Icahn School of Medicine at Mount Sinai)
Cited by 78
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
Acquired Resistance to Immune Checkpoint Inhibitors
|Cancer Cell|2020|927
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
|Nature Medicine|2007|820
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
|Annals of Oncology|2019|413